Worldwide, more Hepatitis C patients have been treated with generic medication than the overpriced branded medication.

Over 90% of patients who have treatment will achieve SVR12 and the data has been presented at the International Liver Congress.

YOU CAN SAFELY ACCESS GENERIC MEDICATION VIA THE REDEMPTION TRIALS

Welcome, Guest
Username: Password: Remember me
Login With :

TOPIC: Immunotherapy in the Treatment of Hepatocellular Carcinoma

Immunotherapy in the Treatment of Hepatocellular Carcinoma 2 months 2 weeks ago #23305

Hopefully this will not be relevant to you, but if you have HCC here is a slide set from Clinical Care Options that outlines the latest advances.

Interestingly Incepta in Bangladesh have a range of generic anti cancer agents. As of a week ago....

Nivolumab has not been launched yet but we have launched Erlotinib, Gefitinib and Osimertinib in addition to Adalimumab, Denosumab and Rituximab.

While there is not a magic bullet(s) (as yet) it would be possible to used combined therapy with generics that are cost prohibitive otherwise.
Attachments:
YMMV
The administrator has disabled public write access.
The following user(s) said Thank You: sabrecat, fitz
Time to create page: 0.137 seconds